Position Statement: Drug Holiday in Osteoporosis Treatment with Bisphosphonates in South Korea
Seung Hun Lee, Hyun Sik Gong, Tae-Hee Kim, Si Young Park, Jung-Ho Shin, Sun Wook Cho, Dong-Won Byun
J Bone Metab. 2015;22(4):167-174. Published online 2015 Nov 30 DOI: https://doi.org/10.11005/jbm.2015.22.4.167
|
Citations to this article as recorded by
Effect of clodronate on gene expression in the peripheral blood of horses
Callie V. Wilcox, Heather K. Knych, Scott A. Katzman, Rick M. Arthur, Veronika Rodriguez, Carrie J. Finno
Journal of Veterinary Pharmacology and Therapeutics.2024; 47(3): 187. CrossRef Sorting Dietary Advice for Bone Health
Connie M. Weaver, Taylor C. Wallace, Sisi Cao
Nutrition Today.2024; 59(4): 149. CrossRef Osteoporosis: Complementary and Integrative Approaches
Khara Lucius
Integrative and Complementary Therapies.2024; 30(4): 181. CrossRef Clodronate detection and effects on markers of bone resorption are prolonged following a single administration to horses
Heather K. Knych, Carrie J. Finno, Scott Katzman, Declan Ryan, Daniel S. McKemie, Philip H. Kass, Rick M. Arthur
Equine Veterinary Journal.2023; 55(4): 696. CrossRef Long-term monitoring of clodronate in equine hair using liquid chromatography-tandem mass spectrometry
Heather K. Knych, D.S. McKemie, S. Yim, S.D. Stanley, R.M. Arthur
Journal of Chromatography B.2023; 1226: 123789. CrossRef Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review
Jinyoung Kim, Chaiho Jeong, Jeongmin Lee, Jeonghoon Ha, Ki-Hyun Baek, Seohyun Kim, Tai Joon An, Chan Kwon Park, Hyoung Kyu Yoon, Jeong Uk Lim
Seminars in Oncology.2023; 50(3-5): 105. CrossRef Detection and residence time of bisphosphonates in bone of horses
Heather K. Knych, Jennifer Janes, Laura Kennedy, Daniel S. McKemie, Rick M. Arthur, Monika A. Samol, Francisco A. Uzal, Mary Scollay
Journal of Veterinary Diagnostic Investigation.2022; 34(1): 23. CrossRef Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
Raed AlRowis, Abdulmalik Aldawood, Mohammed AlOtaibi, Essam Alnasser, Ibrahim AlSaif, Abdullah Aljaber, Zuhair Natto
The Saudi Dental Journal.2022; 34(3): 202. CrossRef Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
Allen Herng Shouh Hsu, Chun-Hsien Yen, Feng-Chih Kuo, Cheng-Ta Wu, Tsan-Wen Huang, Juei-Tang Cheng, Mel S. Lee
Pharmaceuticals.2022; 15(4): 420. CrossRef Pharmacological treatment of osteoporosis: 2022 update
Yunkyung Jeon, In-Joo Kim
Journal of the Korean Medical Association.2022; 65(4): 241. CrossRef A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling
Hyun Ki Kang, Cho Yeon Park, Sung Youn Jung, Seung Bin Jo, Byung-Moo Min
Tissue Engineering and Regenerative Medicine.2022; 19(6): 1359. CrossRef Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
Kaleen N. Hayes, Elizabeth M. Winter, Suzanne M. Cadarette, Andrea M. Burden
Journal of Clinical Medicine.2021; 10(5): 1140. CrossRef Bisphosphonate: An Invaluable Medication or Abandoned Acid?
HoeJeong Chung, Jin Woo Lee, Jae Woong Um, Hoon-Sang Sohn
Journal of the Korean Fracture Society.2021; 34(3): 122. CrossRef Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case‐Control Study
Lanny V. Griffin, Elizabeth Warner, Saroj Palnitkar, Shijing Qiu, Mahalakshmi Honasoge, Shawna G. Griffin, George Divine, Sudhaker D. Rao
JBMR Plus.2021;[Epub] CrossRef Improving Bisphosphonate Use and Evaluation in a Rural Family Medicine Practice
Megan Adelman, Shauna Assadzandi, Jun Xiang
The Senior Care Pharmacist.2021; 36(3): 152. CrossRef Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment
So Young Park, Seong Hee Ahn, Jun-Il Yoo, Youn-Jee Chung, Yun Kyung Jeon, Byung-Ho Yoon, Ha Young Kim, Seung Hun Lee, Jehoon Lee, Seongbin Hong
Journal of Bone Metabolism.2019; 26(4): 213. CrossRef Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea
Young-Kyun Lee, Soyeon Ahn, Kyoung Min Kim, Chang Suk Suh, Kyung-Hoi Koo
Journal of Korean Medical Science.2018;[Epub] CrossRef Bone Turnover in Osteoporotic Women During Long-Term Oral Bisphosphonates Treatment: Implications for Treatment Failure and “Drug Holiday” in the Real World
Yair Liel, Ygal Plakht, Muhammad Abu Tailakh
Endocrine Practice.2017; 23(7): 787. CrossRef Pharmacologic treatment of osteoporosis
Yong-Ki Min
Journal of the Korean Medical Association.2016; 59(11): 847. CrossRef Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
Yong-Dae Kwon, Deog-Yoon Kim
Dentistry Journal.2016; 4(4): 41. CrossRef
|